DE69015220T2 - Glycocyamidin-Derivate. - Google Patents

Glycocyamidin-Derivate.

Info

Publication number
DE69015220T2
DE69015220T2 DE69015220T DE69015220T DE69015220T2 DE 69015220 T2 DE69015220 T2 DE 69015220T2 DE 69015220 T DE69015220 T DE 69015220T DE 69015220 T DE69015220 T DE 69015220T DE 69015220 T2 DE69015220 T2 DE 69015220T2
Authority
DE
Germany
Prior art keywords
glycocyamidine
derivatives
alkyl group
hydrogen
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69015220T
Other languages
English (en)
Other versions
DE69015220D1 (de
Inventor
Ko Nakamura
Kazuhara Ienaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of DE69015220D1 publication Critical patent/DE69015220D1/de
Application granted granted Critical
Publication of DE69015220T2 publication Critical patent/DE69015220T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69015220T 1989-02-01 1990-01-31 Glycocyamidin-Derivate. Expired - Fee Related DE69015220T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2466989 1989-02-01

Publications (2)

Publication Number Publication Date
DE69015220D1 DE69015220D1 (de) 1995-02-02
DE69015220T2 true DE69015220T2 (de) 1995-05-11

Family

ID=12144550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69015220T Expired - Fee Related DE69015220T2 (de) 1989-02-01 1990-01-31 Glycocyamidin-Derivate.

Country Status (7)

Country Link
US (1) US4957936A (de)
EP (1) EP0381628B1 (de)
JP (1) JP2957217B2 (de)
AT (1) ATE115951T1 (de)
DE (1) DE69015220T2 (de)
DK (1) DK0381628T3 (de)
ES (1) ES2066181T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221689B (de) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
EP1686990B1 (de) * 2003-11-21 2012-09-19 U.S. Army Medical Research and Materiel Command 2-guanidinylimidazolidindion-verbindungen und verfahren zu ihrer herstellung und verwendung
CN102859357A (zh) 2010-04-27 2013-01-02 希森美康株式会社 肾脏病诊断用标志物及其利用
EP3416645A4 (de) * 2016-02-18 2019-10-16 Merck Sharp & Dohme Corp. Verbindungen zur behandlung von malaria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE251937C (de) *
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives

Also Published As

Publication number Publication date
JP2957217B2 (ja) 1999-10-04
DK0381628T3 (da) 1995-05-01
US4957936A (en) 1990-09-18
EP0381628B1 (de) 1994-12-21
DE69015220D1 (de) 1995-02-02
ATE115951T1 (de) 1995-01-15
EP0381628A3 (de) 1991-05-02
EP0381628A2 (de) 1990-08-08
ES2066181T3 (es) 1995-03-01
JPH02288867A (ja) 1990-11-28

Similar Documents

Publication Publication Date Title
AU515774B2 (en) Benzopyran derivatives
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DE69004164D1 (de) Diphenylharnstoffderivate.
ATE59391T1 (de) Oliglucosidderivate.
FI914187A (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
ES548357A0 (es) Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2.
ES2188481T3 (es) Derivados de polinalbufina.
MX170732B (es) Composicion de derivados de succinimida y su uso
ES2065994T3 (es) Beta-dicetonas substituidas.
DE69015220D1 (de) Glycocyamidin-Derivate.
FI854596A0 (fi) Nytt foerfarande foer uppdelning av racemiska -naftylpropionsyror i optiska isomerer.
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
DK0485204T3 (da) Fremgangsmåde til fremstilling af 3-alkoxymethyl-cephalosporin-derivater
KR900018083A (ko) 에폭시숙신산 유도체
ATE217311T1 (de) Cyclopropancyclus enthaltende purinderivate
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
ES2072299T3 (es) Derivados de 3-desoxi-micaminosil-tilonolida.
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
DK0455899T3 (da) Prostaglandin I-analog
ES2139670T3 (es) Derivados de 1-fenilpirrolidona con actividad optica y preparacion de los mismos.
KR840001554A (ko) 벤즈아미드 유도체의 제법
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona
TH13791EX (th) อนุพันธ์ต่างๆของกรดบิวไทริค

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee